Biegel & Waller’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,807
Closed -$1.73M 82
2019
Q1
$1.73M Sell
11,807
-5,313
-31% -$770K 0.89% 20
2018
Q4
$2.29M Sell
17,120
-36,146
-68% -$5.93M 1.35% 19
2018
Q3
$10.1M Sell
53,266
-3,441
-6% -$632K 5.86% 6
2018
Q2
$9.45M Sell
56,707
-323
-0.6% -$51.9K 5.89% 6
2018
Q1
$9.6M Buy
57,030
+78
+0.1% +$13.1K 6.1% 7
2017
Q4
$9.32M Sell
56,952
-1,715
-3% -$308K 5.41% 8
2017
Q3
$12M Sell
58,667
-1,716
-3% -$399K 7.56% 5
2017
Q2
$14.7M Sell
60,383
-4,611
-7% -$1.08M 8.96% 4
2017
Q1
$15.5M Sell
64,994
-17,099
-21% -$3.98M 10.71% 4
2016
Q4
$17.3M Buy
+82,093
New +$17M 12.07% 4

Other funds holding AGN

Biegel & Waller's AGN Position: Q2 2019 in Review

Biegel & Waller sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 11,807 shares — an estimated $1.73M sold.

Biegel & Waller first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $17.3M in Q4 2016. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Biegel & Waller reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Biegel & Waller sold 11,807 Allergan plc shares in Q2 2019, an estimated $1.73M.
  • Biegel & Waller first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • Biegel & Waller's Allergan plc position peaked at $17.3M in Q4 2016.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Biegel & Waller's 13F filing for Q2 2019, filed 23 Jul 2019.